EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Electrochemical Acetylcholinesterase Sensors for Anti-Alzheimer’s Disease Drug Determination

Alexey Ivanov iD, Rezeda Shamagsumova, Marina Larina, Gennady Evtugyn iD

Biosensors · 09.02.2024 · 14 (2) · 93

DOI: 10.3390/bios14020093 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biosensors, online erschienen am 09.02.2024. Verfasst von Alexey Ivanov und 3 weiteren Autor:innen. Beteiligte Einrichtung: A.M. Butlerov' Chemistry Institute, Kazan Federal University, 18 Kremlevskaya Street, 420008 Kazan, Russia. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kazan Federal University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurodegenerative diseases and Alzheimer’s disease (AD), as one of the most common causes of dementia, result in progressive losses of cholinergic neurons and a reduction in the presynaptic markers of the cholinergic system. These consequences can be compensated by the inhibition of acetylcholinesterase (AChE) followed by a decrease in the rate of acetylcholine hydrolysis. For this reason, anticholinesterase drugs with reversible inhibition effects are applied for the administration of neurodegenerative diseases. Their overdosage, variation in efficiency and recommendation of an individual daily dose require simple and reliable measurement devices capable of the assessment of the drug concentration in biological fluids and medications. In this review, the performance of electrochemical biosensors utilizing immobilized cholinesterases is considered to show their advantages and drawbacks in the determination of anticholinesterase drugs. In addition, common drugs applied in treating neurodegenerative diseases are briefly characterized. The immobilization of enzymes, nature of the signal recorded and its dependence on the transducer modification are considered and the analytical characteristics of appropriate biosensors are summarized for donepezil, huperzine A, rivastigmine, eserine and galantamine as common anti-dementia drugs. Finally, the prospects for the application of AChE-based biosensors in clinical practice are discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseHumansCholinesterase InhibitorsAcetylcholinesterasePharmaceutical PreparationsPiperidinesIndans

Stichwörter der Autor:innen

acetylcholinesterasedrug determinationelectrochemical biosensorreversible inhibition

Substanzen

Cholinesterase InhibitorsAcetylcholinesterasePharmaceutical PreparationsPiperidinesIndans

Autor:innen und Institutionen

  • A.M. Butlerov' Chemistry Institute, Kazan Federal University, 18 Kremlevskaya Street, 420008 Kazan, Russia.
  • Institute of Fundamental Medicine and Biology, Kazan Federal University, 18 Kremlevskaya Street, 420008 Kazan, Russia.
  • Analytical Chemistry Department, Chemical Technology Institute, Ural Federal University, 19 Mira Street, 620002 Ekaterinburg, Russia.

ORCID-Profile: Alexey Ivanov, Gennady Evtugyn

Förderung

  • Kazan Federal University

Zitieren

APA

Ivanov, A., Shamagsumova, R., Larina, M., & Evtugyn, G. (2024). Electrochemical Acetylcholinesterase Sensors for Anti-Alzheimer’s Disease Drug Determination. Biosensors, 14(2), 93. https://doi.org/10.3390/bios14020093

Vancouver

Ivanov A, Shamagsumova R, Larina M, Evtugyn G. Electrochemical Acetylcholinesterase Sensors for Anti-Alzheimer’s Disease Drug Determination. Biosensors. 2024;14(2):93. doi:10.3390/bios14020093

BibTeX
@article{Ivanov2024,
  author = {Ivanov, Alexey and Shamagsumova, Rezeda and Larina, Marina and Evtugyn, Gennady},
  title = {Electrochemical Acetylcholinesterase Sensors for Anti-Alzheimer’s Disease Drug Determination},
  journal = {Biosensors},
  year = {2024},
  volume = {14},
  number = {2},
  pages = {93},
  doi = {10.3390/bios14020093}
}
Kostenlos starten →